The Alzheimer's Accountability and Investment Act (Public Law 118-93), enacted on October 1, 2024, mandates that the National ...

A University of the Basque Country (UPV/EHU) study proves that the WIN55.212-2 drug protects the brain and reverses the ...

The finding has implications for all of us, write Harvard physician-researchers Christopher Worsham and Anupam Jena.

Zunveyl, an oral medication, is a better-tolerated version of galantamine for managing mild to moderate Alzheimer's symptoms.

Alzheimer's disease is the most common type of dementia. Here, we break down what to know about this disease, including: What ...

This has demonstrated the potential of palbociclib in treating Alzheimer’s disease,” Chen said. The research shows the drug ...

“There are things that we can do at all stages of our lives deliberately,” says Prof Schott. “It’s never too early to start ...

Biogen (BIIB) and Eisai's (ESALF) (ESAIY) announce that U.S. FDA agreed to review their subcutaneous form of Alzheimer's ...

Nearly 10% of people live with chronic kidney disease—in other words, their kidneys can't adequately filter waste from their ...

"Our study results forecast a dramatic rise in the burden from dementia in the United States over the coming decades, with ...

A new study found that dementia cases in the United States are projected to double from more than 500,000 in 2020 to about 1 million by 2050.

Children in the same family may experience the news of an impending death in different ways. A child’s anticipatory grief may ...